This site is intended for US health care professionals only.
158 days to go: ASP+6% CMS reimbursement for proven non-opioids used in all outpatient surgical settings is coming January 1, 2025.
Increased reimbursement in the ambulatory surgery center and hospital outpatient department setting
Effective January 1, 2025, Medicare will provide separate ASP+6% reimbursement for proven non-opioid pain management, like EXPAREL, thanks to the NOPAIN Act.1-3
This will expand reimbursement beyond the ambulatory surgery center, where EXPAREL already has reimbursement via code C9290.
Keep me informed about the NOPAIN Act
ASP, average sales price; NOPAIN, Non-Opioids Prevent Addiction in the Nation.
References: 1. Congress.gov. One hundred seventeenth congress of the United States of America. Accessed June 12, 2024. https://www.congress.gov/117/bills/hr2617/BILLS-117hr2617enr.pdf 2. CMS.gov. Medicare part B drug average sales price. Accessed June 5, 2024. https://www.cms.gov/medicare/payment/fee-for-service-providers/part-b-drugs/average-drug-sales-price 3. EXPAREL Prescribing Information. San Diego, CA; Pacira Pharmaceuticals, Inc., November 2023.